It is concluded that mislocalization of AQP4 from perivascular end-feet to the cell body in reactive astrocytes is associated with the reduction of efficacy of the glymphatic system and the onset of pathological cerebral findings following AD, TBI, and stroke (Figure 2). This evidence concerns the gene AQP4 and stroke disorder.